EUVIMEDEUVIMED entdecken
Crossref

From Antipsychotic to Neuroprotective: Computational Repurposing of Fluspirilene as a Potential PDE5 Inhibitor for Alzheimer's Disease

Kunal Bhattacharya iD, Atanu Bhattacharjee, Manodeep Chakraborty, Dibyajyoti Das, Keshav Raj Paudel

Journal of Computational Chemistry · 2025

DOI: 10.1002/jcc.70029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Computational Chemistry, 2025. Verfasst von Kunal Bhattacharya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Royal School of Pharmacy, The Assam Royal Global University, Guwahati, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Antipsychotic Agents, Drug Repositioning, Phosphodiesterase 5 Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphodiesterase 5 (PDE5) inhibitors have shown great potential in treating Alzheimer's disease by improving memory and cognitive function. In this study, we evaluated fluspirilene, a drug commonly used to treat schizophrenia, as a potential PDE5 inhibitor using computational methods. Molecular docking revealed that fluspirilene binds strongly to PDE5, supported by hydrophobic and aromatic interactions. Molecular dynamics simulations confirmed that the fluspirilene–PDE5 complex is stable and maintains its structural integrity over time. Binding energy calculations further highlighted favorable interactions, indicating that the drug forms a strong and stable bond with PDE5. Additional analyses, including studies of protein dynamics and energy landscape mapping, revealed how the drug interacts dynamically with PDE5, adapting to different conformations and maintaining stability. These findings suggest that fluspirilene may modulate PDE5 activity, potentially offering therapeutic benefits for Alzheimer's disease. This study provides strong evidence for repurposing fluspirilene as a treatment for Alzheimer's and lays the foundation for further experimental and clinical investigations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAntipsychotic AgentsDrug RepositioningPhosphodiesterase 5 InhibitorsNeuroprotective AgentsCyclic Nucleotide Phosphodiesterases, Type 5PyrimidinesHumansMolecular Docking SimulationMolecular Dynamics SimulationMolecular Structure

Stichwörter der Autor:innen

Alzheimer'sfluspirilenemolecular dockingmolecular dynamics simulationsphosphodiesterase 5 (PDE5) inhibitor

Substanzen

Antipsychotic AgentsPhosphodiesterase 5 InhibitorsNeuroprotective AgentsCyclic Nucleotide Phosphodiesterases, Type 5Pyrimidines

Autor:innen und Institutionen

  • Royal School of Pharmacy, The Assam Royal Global University, Guwahati, India.
  • Department of Pharmaceutical Chemistry, Pratiksha Institute of Pharmaceutical Sciences, Guwahati, India.
  • Department of Pharmacology, Himalayan Pharmacy Institute, Majhitar, India.
  • Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, India.
  • Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, New South Wales, Australia.

ORCID-Profile: Kunal Bhattacharya

Zitieren

APA

Bhattacharya, K., Bhattacharjee, A., Chakraborty, M., Das, D., & Paudel, K. R. (2025). From Antipsychotic to Neuroprotective: Computational Repurposing of Fluspirilene as a Potential PDE5 Inhibitor for Alzheimer's Disease. Journal of Computational Chemistry. https://doi.org/10.1002/jcc.70029

Vancouver

Bhattacharya K, Bhattacharjee A, Chakraborty M, Das D, Paudel KR. From Antipsychotic to Neuroprotective: Computational Repurposing of Fluspirilene as a Potential PDE5 Inhibitor for Alzheimer's Disease. Journal of Computational Chemistry. 2025. doi:10.1002/jcc.70029

BibTeX
@article{Bhattacharya2025,
  author = {Bhattacharya, Kunal and Bhattacharjee, Atanu and Chakraborty, Manodeep and Das, Dibyajyoti and Paudel, Keshav Raj},
  title = {From Antipsychotic to Neuroprotective: Computational Repurposing of Fluspirilene as a Potential PDE5 Inhibitor for Alzheimer's Disease},
  journal = {Journal of Computational Chemistry},
  year = {2025},
  doi = {10.1002/jcc.70029}
}
Kostenlos starten →